| RS1305299665 |
NAGLU
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS1305301849 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1305314328 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1305333312 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1305337032 |
NPR2;SPAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature with nonspecific skeletal abnormalities, Acromesomelic dysplasia 1 |
| RS1305342570 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS1305369403 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1305404947 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1305408254 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1305436274 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS1305442000 |
AAAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS1305448140 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1305450307 |
EXOSC9
|
Health Risk |
Pathogenic |
— |
| RS1305450457 |
EXPH5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 4, localized or generalized intermediate |
| RS1305459936 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1305460528 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1305511499 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1305519459 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1305523001 |
SMAD2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1305523200 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1305531440 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Hereditary cerebral hemorrhage with amyloidosis |
| RS1305539945 |
SPG7
|
Health Risk |
Likely pathogenic |
— |
| RS1305542291 |
SCAPER
|
Health Risk |
Pathogenic/Likely pathogenic |
Moderate intellectual disability, Rod-cone dystrophy |
| RS1305555370 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1305562386 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1305592691 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1305602800 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1305605404 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1305609812 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microscopic hematuria, COL4A4-related disorder |
| RS1305630681 |
SOX18
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, Hypotrichosis-lymphedema-telangiectasia syndrome |
| RS1305635836 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1305642045 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1305652887 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1305653433 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 2 |
| RS1305659962 |
SPTAN1
|
Health Risk |
Likely pathogenic |
— |
| RS1305675114 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1305687130 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1305702728 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1305706304 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS1305708707 |
FAN1
|
Health Risk |
Likely pathogenic |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS1305711807 |
TIMM50
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 9, 3-methylglutaconic aciduria type 9 |
| RS1305721973 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1305740166 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1305782685 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1305784673 |
HADHB
|
Health Risk |
Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS1305797678 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1305819869 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1305821156 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 1, See cases |
| RS1305836268 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1305848585 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1305851796 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1305851892 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1305866080 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1305905662 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1305924233 |
F8
|
Health Risk |
Likely pathogenic |
— |
| RS1305928655 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1305948343 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1305965061 |
SOX4
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 10, Coffin-Siris syndrome 10 |
| RS1305966854 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1305971005 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1305971341 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS1305972382 |
NCDN
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with infantile epileptic spasms, Neurodevelopmental disorder with infantile epileptic spasms |
| RS1305986308 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1305999116 |
TULP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1306034404 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1306035407 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS1306036000 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, GRIN2A-related complex neurodevelopmental disorder |
| RS1306040798 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1306053610 |
COL6A3
|
Health Risk |
Likely pathogenic |
— |
| RS1306056914 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1306059500 |
IARS2
|
Health Risk |
Pathogenic |
— |
| RS1306107119 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1306111238 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1306112783 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Congenital myasthenic syndrome |
| RS1306120659 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1306125686 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1306143550 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1306216582 |
PRDM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1306223822 |
PDHX
|
Health Risk |
Likely pathogenic |
— |
| RS1306228988 |
GRN
|
Health Risk |
Conflicting classifications of pathogenicity |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1306231185 |
MKKS
|
Health Risk |
Pathogenic |
Progressive cone dystrophy (without rod involvement), Bardet-Biedl syndrome |
| RS1306247629 |
CYP2R1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D hydroxylation-deficient rickets, type 1B |
| RS1306253222 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS1306256963 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1306259287 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS1306265578 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS1306272176 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1306288607 |
CYP11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS1306292205 |
TMPRSS3
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1306330581 |
CEP78
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy and hearing loss 1, Cone-rod dystrophy and hearing loss 1 |
| RS1306336545 |
LIPA
|
Health Risk |
Likely pathogenic |
Lysosomal acid lipase deficiency, Lysosomal acid lipase deficiency |
| RS1306393544 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS1306395752 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) |
| RS1306403056 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1306417990 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1306442938 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1306444586 |
INPP4A
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal dominant 1 |
| RS1306460268 |
LRP5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1306473047 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1306475361 |
SDHD
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Paragangliomas with sensorineural hearing loss |